We use cookies on this website to provide a user experience that’s more tailored to you. By continuing to use the website, you are giving your consent to receive cookies on this site. Read more about our Cookie Policy and Privacy Policy.

I accept
Malaysia
Hotline Contact Join Us
 Follow
< Back
Products & Services
Networking Information Security Cloud Solutions Cloud Data Center Internet Services Managed Services Europe Solutions
< Back
Solutions
Architecture, Engineering & Construction Automobile BFSI Logistics & Transportation Manufacturing Legal & Accounting Services Retail Healthcare
< Back
Technology & Services
Consulting Services Customer Services
< Back
About Us
Our Company Global Ecosystem Partners News Center Accreditation & Awards Careers
< Back
Resources Center
Product Leaflets New Offering Videos White Paper Success Stories Blog
< Back
Contact Us
Contact Us Regional Contacts Services Hotline

Home > Resources Center > Blog

2024-03-26

Novotech Wins "2024 National Award for Outstanding Practice and Team in Pharmaceutical and Healthcare Digitalization" and Opens a Way for Pharmaceutical Globalization with its Digital Intelligence

The 2024 National CIO Conference on Pharmaceuticals, Healthcare and Retailing (2024全國醫藥大健康和消費零售CIO大會, "the Conference"), jointly organized by D1Net (企業網D1Net), China Enterprise Digitalization Alliance (中國企業數字化聯盟) and Xinzhongzhi (信眾智 – CIO智力輸出及社交平台), was concluded in Shanghai lately. Under the theme "Enabling Sustainable Development with Digital Intelligence", it gathered CIOs of leading enterprises in the pharmaceutical, healthcare and retailing industries, as well as service providers of industrial digitalization including China Entercom. As a trusted DICT service partner, it was an honor for China Entercom to share its in-depth understanding of business scenarios across industries and its unrivaled experience in digitalization, intelligentization and digital transformation with the delegates in the two sessions.

A big news was also unveiled at the Conference. Novotech Pharmaceutical Technology (Shanghai) Co., Ltd. (“Novotech"), a renowned user of China Entercom’s DICT services and one of the world’s most influential full-service clinical Contract Research Organizations (CRO) , was awarded the "2024 National Award for Outstanding Practice and Team in Pharmaceutical and Healthcare Digitalization" (2024年度全國醫藥大健康數字化優秀案例及優秀團隊獎) for its excellence in digitalization, intelligent applications, innovative capabilities, and especially its deployment of migrating the entire operation system to the cloud. Beyond the recognition of Novotech’s success, the award acknowledged its unparalleled contribution in accelerating transformation towards digitalization and intelligentization in the pharmaceutical and healthcare industry.

Novotech Wins

Novotech Wins

Mr. Wanchuan Yong, IT Project Manager, received the award on behalf of Novotech

Expediting Pharmaceutical Globalization as a Pioneer in Digital Intelligence and Innovation

Novotech is the leading Asia Pacific centred biotech CRO with global execution capabilities - more than 3,000 employees in 34 office locations worldwide are dedicated to working with clients mainly from the Asia-Pacific regions, the United States, and Europe. The company is committed to carrying out clinical trials that focus on biotechnologies and has been involved in over 5,000 clinical projects ranging from Phase I to Phase IV trials. It also operates laboratories and Phase I clinical centers, and offers drug development consulting services and FDA regulatory services. [1]

The deployment of Novotech’s globalization was backed by its enhanced digital capabilities in operations. Given that the pharmaceutical and healthcare industry is one of the innovative sectors generating new quality productive forces (新質生產力), which are mandatory in fostering industrial transformation and qualitative development, these forces can be developed through digital intelligence and innovation. In other words, digitalization not only improves IT operations and technology but is also a necessity to boost business growth. Novotech was quick to notice this trend, and in addition to increasing investments in digitalization, it introduced advanced technologies including cloud computing, big data and artificial intelligence. In practice, the migration of the operation system to the cloud that earned Novotech the "2024 National Award for Outstanding Practice and Team in Pharmaceutical and Healthcare Digitalization" showcases the excellent use of cloud computing. With digitalization, Novotech has integrated technology and operation by realizing business model innovation, optimizing operations, and improving customer experience.

As a result of digitalization, Novotech succeeded in improving its overall digitalization level and reaping significant economic benefits, notably through a more accurate understanding of market dynamics, a more efficient approach to clinical research, and a faster response to customer needs. Digitalization has enabled Novotech to maintain its core competencies in the industry and to identify new market opportunities that will lead to continued business growth.

Igniting New Quality Productive Forces with Digital Intelligence to Spark New Dynamics

Over the past twenty years, the development course of China Entercom has documented that countless pharmaceutical and healthcare enterprises have evolved from informatization and digitalization to intelligentization, and has executed in-depth and profound digital transformation processes for them. To this day, China Entercom has maintained a pioneering status with its solid foundation of technology and innovation as well as years of experience, so as to seize new quality productive forces and new opportunities to reach new heights.

Backed by China Entercom’s "Cloud, Network and Security" one-stop-shop solutions to enhance network security and the stability of digitalization for globalization, Novotech has been able to consolidate its position in the Asia-Pacific region and promote high-quality development around the world.

Together with the parent company CITIC Telecom CPC and CITIC Group, China Entercom possesses extensive ICT resources, including nearly 170 points of presence (POPs), 60+ SD-WAN gateways and 21 cloud service platforms. These are deployed all around the world, particularly in the regions along the "Belt and Road”, the Middle East, the BRICS countries and the RCEP countries, which made China Entercom strongly competitive in laying out the globalization blueprint and the global interconnections for Novotech.

The background of China Entercom is what makes it an experienced cloud managed service provider in the ICT industry for over two decades, and has laid a solid foundation for its SmartCLOUD™ Cloud Computing Solution and cloud infrastructure that is recognized by the Trusted Cloud Services (TRUCS) Certification, multiple ISO certifications and industry experts. It is a tailor-made and worry-free solution that allows customization and pay-per-use, not to mention full lifecycle services covering consultation, deployment, implementation and operation and maintenance.

Moreover, TrustCSI™ Unified Threat Management (UTM) is another solution offered by China Entercom to stabilize the operation of Novotech. Coupled with three 24/7 Security Operations Centers (SOCs), it acts as the primary security gate to identify and resolve problems even before Novotech knows about them. To overcome the sophisticated and ever-changing cyber threats with a more robust and intelligent security solution, China Entercom has incorporated AI technology into its latest and ground-breaking TrustCSI™ 3.0 Cybersecurity Solutions, optimizing the "Cloud, Network and Security" solutions to proactively safeguard enterprises continuously and intelligently.

China Entercom’s "Cloud, Network and Security" integrated solutions are known for its high quality and reliability. In addition to enhancing the operation efficiency of Novotech and accelerating its globalization progress, the solution has unlocked more business profits as the employees can focus on the core businesses.

To become a strong pillar of global drug development, Novotech sets out to strengthen its infrastructure to offer better CRO services around the world. [2] China Entercom, as a trusted DICT service partner, is dedicated to facilitating digitalization, intelligentization and digital transformation in the pharmaceutical and healthcare industry. For empowering Novotech and more enterprises to deploy and enhance digitalization and intelligentization, the cooperation with Novotech will certainly be intensified to reinforce the "Cloud, Network and Security" foundation that incorporates digital intelligence, and together they can explore more innovative applications to advance the digitalization of the biotechnology industry.

Novotech Wins

Highlights at the Conference

About Novotech

Novotech

Novotech is the leading Asia Pacific centered biotech CRO with global execution capabilities - more than 3,000 employees in 34 office locations worldwide are dedicated to working with clients mainly from the Asia-Pacific regions, the United States, and Europe. The company is committed to carrying out clinical trials that focus on biotechnologies, and has been involved in over 5,000 clinical projects ranging from Phase I to Phase IV trials. It also operates laboratories and Phase I clinical centers, and offers drug development consulting services and FDA regulatory services.

References

[1] "About Novotech", Source: Novotech WeChat Official Account
[2] "Highlights | Novotech Annual Celebration: Uniting for Shared Success", Source: Novotech WeChat Official Account

Featured
【Important Notice】Major Changes to VMware Licensing Policy!
【Important Notice】Major Changes to VMware Licensing Policy!
Exploring CITIC Telecom Data Center】Embracing AI Technologies and Cultivating Future Innovators
Exploring CITIC Telecom Data Center】Embracing AI Technologies and Cultivating Future Innovators
What is Multi-Cloud Solution? Exploring Flexibility, Agility, and Cost Optimization for Enterprises
What is Multi-Cloud Solution? Exploring Flexibility, Agility, and Cost Optimization for Enterprises
Novotech Wins
Novotech Wins "2024 National Award for Outstanding Practice and Team in Pharmaceutical and Healthcare Digitalization" and Opens a Way for Pharmaceutical Globalization with its Digital Intelligence
【Security Matters】AI+ Cybersecurity: Unleashing Comprehensive Protection for Enterprise Assets
【Security Matters】AI+ Cybersecurity: Unleashing Comprehensive Protection for Enterprise Assets
Select Tags
Artificial Intelligence Data Analytics Cloud Computing Network Customer Experience Data Center Ecosystem Sustainability Information Security Intelligent Innovation SASE Blockchain SD-WAN Digital Transformation
Contact Us
Company Name:
Contact Name:
Title:
Contact Phone Number:

-

Email:
Remark

Please slide to verify

Products & Services
Networking Information Security Cloud Solutions Cloud Data Center Internet Services Managed Services Europe Solutions
Solutions
Architecture, Engineering & Construction Automobile BFSI Logistics & Transportation Manufacturing Legal & Accounting Services Retail Healthcare
Technology & Services
Consulting Services Customer Services
Resources Center
Product Leaflets New Offering Videos White Paper Success Stories Blog
About Us
Our Company Global Ecosystem Partners News Center Accreditation & Awards Careers
Contact Us

General Enquiry / Sales Hotline +60 3 2280 1500

Service Hotline +60 03 2280 1488

Contact Us

Follow Us

Sitemap Disclaimer Net Abuse Policy Privacy Notice Cookie Policy Accessibility Statement 中信集團品牌認證 | 中信雲賦能

Copyright © 中信國際電訊(信息技術)有限公司 CITIC Telecom International CPC Limited

Hotline
Contact
Join Us
Follow

Thank you for your enquiry.


We will contact you shortly.
Need help? Chat with CPC Chatbot
Supported browsers: Latest versions of IE11, Firefox, Chrome and Safari.
Terms & Conditions
Welcome to CITIC Telecom International CPC Limited. Your conversation with CPC Chatbot may be recorded for training, quality control and dispute handling purposes. By clicking “Continue” and using CPC Chatbot, you accept and agree to be bound by our Privacy Policy and give your consent to receive cookies on this site. Read more about our Cookie Policy and Privacy Policy.
Continue